Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEX Biometrics ASA Investor Presentation 2021

Jan 7, 2021

3633_rns_2021-01-07_f352ff29-9bdb-41c9-bc34-a6f35df41f7b.html

Investor Presentation

Open in viewer

Opens in your device viewer

IDEX Biometrics to Participate at the Needham Growth Conference on 13 January 2021

IDEX Biometrics to Participate at the Needham Growth Conference on 13 January 2021

Oslo, Norway, 7 January 2021: IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF)

is a leading provider of advanced fingerprint identification and authentication

solutions. CEO Vince Graziani and CFO Derek D'Antilio will participate at the

23rd Annual Needham Growth Conference on Wednesday 13 January 2021, which is

being held as a virtual event.

Portfolio managers and analysts who would like to request a meeting with

management should contact their Needham representative

([email protected] (mailto:[email protected])) or IDEX's

investor relations.

About IDEX Biometrics

IDEX Biometrics ASA is a leading provider of fingerprint identification

technologies offering simple, secure and personal touch-free authentication for

all. We help people make payments, prove their identity, gain access to

information, unlock devices or gain admittance to buildings. We invent,

engineer, and commercialize these secure and safe yet incredibly user-friendly

solutions. Our total addressable market represents a fast growing multi-billion-

unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics

U.S. Investor Contact:

Brett L Perry, Shelton Group

E-mail: [email protected] (mailto:[email protected])

Tel: +1 214 272 0070

Company Contacts:

Marianne Bøe, Investor Relations

E-mail: [email protected] (mailto:[email protected])

Tel: + 47 918 00186

Derek D'Antilio, Chief Financial Officer

E-mail: [email protected]

(mailto:[email protected])

Tel: +1 978 273 1344

This information is subject to the disclosure requirements pursuant to Section

5-12 the Norwegian Securities Trading Act